SLS Latest Press Releases

-- September 25, 2026 --

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer Globe Newswire 1:00 PM

-- September 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PRNewswire 5:34 PM

-- September 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS Globe Newswire 8:12 PM

-- September 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PRNewswire 10:02 AM

-- September 3, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PRNewswire 10:16 AM

-- September 2, 2026 --

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer Globe Newswire 8:30 AM

-- September 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS Globe Newswire 6:23 PM

-- August 11, 2026 --

SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes